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ABSTRAK 
 
 
Latarbelakang: Secara kesuluruhannya, telah diakui di peringkat dunia bahawa gejala 
loya-loya dan muntah selepas pembedahan berlaku dengan insiden sebanyak 30% 
daripada  semua pesakit yang dibius. Ia adalah gejala yang sangat menganggu pesakit 
selepas pembedahan. Ia boleh ditangani dengan perubatan moden seperti metoclopramide 
atau  perubatan alternatif, seperti halia yang digunakan dalam kajian ini. 
 
Metodologi: Ini adalah suatu kajian secara ‘randomized controlled trial’ untuk mengkaji 
halia sebagai agen anti muntah yang dibandingkan dengan ubat metoclopramide yang 
biasa digunakan dalam bidang anestesia dan perubatan. Pesakit-pesakit akan dimasukkan 
secara rawak dan ‘double blinded’ dalam dua kumpulan iaitu kumpulan A yang 
mengambil ubat metoclopramide dan kumpulan B yang mengambil halia. Analisis 
statistik dijalankan untuk melihat kaitan gejala loya-loya, ‘retching’ dan muntah selepas 
pembedahan dengan kedua-dua kumpulan ini. 
 
Hasilan:  Faktor-faktor karektor demografi adalah agak sama apabila dibandingkan 
kedua-dua kumpulan kajian ini. Suatu hasil yang signifikan dari segi statistik telah 
diperolehi melalui kajian ini, iaitu perbandingan keberkesanan halia dengan ubat 
metoclopramide dalam mengelakkan muntah selepas pembedahan pada 0 hingga 6 jam, 
dengan nilai p =0.025 melalui ‘Fisher’ exact test’. Keputusan kajian yang lain-lain seperti 
perbandingan keberkesanan halia berbanding ubat metoclopramide dalam mengelakkan 
 xii 
loya-loya dan ‘retching’ selepas pembedahan pada 0 hingga 6 jam dan selepas 6 hingga 
12 jam serta mengelakan muntah selepas 6 hingga 12 jam adalah  tidak signifikan secara 
statistik. 
Kesimpulan: Keputusan positif halia yang diperolehi melalui kajian ini adalah sesuatu 
yang mengujakan dalam bidang anestesia dan perubatan. Yakni, kami berharap ini akan 
memberikan pemangkin yang diperlukan untuk kajian di masa depan tentang 
keberkesanan halia di Malaysia. Seterusnya, meningkatkan mutu perubatan secara 
holistik di Malaysia. 
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ABSTRACT 
 
 
Background: In general in today’s modern world, post operative nausea and vomiting is 
as common as 30 % of the total patients going under anaesthesia through multiple studies 
(Lermen J. et al. 1992, Saeeda I. et al. 2004) done around the globe. Post operative 
nausea and vomiting is a very disturbing outcome after anaesthesia. It may be managed 
with modern medicine, such as metoclopramide or with alternative medication, such as 
ginger as studied in this dissertation.   
 
Methodology: This is a randomized controlled trial study to look at effectiveness of 
ginger against a commonly used, metoclopramide as an anti emetic agent to prevent post 
operative nausea and vomiting. Patients were grouped into 2 comparable arms in a double 
blinded method to look at outcome symptoms of nausea, retching and vomiting. Primary 
and secondary statistical analysis were used to look at the association of post operative 
nausea, retching and vomiting against tablet metoclopramide and ginger given prior to 
anaesthesia. 
 
Results: The demographic characteristics were comparable between both groups. There 
was a significant finding statistically with p-value of 0.025 through Fisher’ exact test for 
association between post operative vomiting within 6 hours for ginger group against 
metoclopramide group. Other findings of the outcome symptoms of nausea and retching 
within 0 to 6 hours and more than 6 hours to 12 hours as well as vomiting more than 6 
hours to 12 hours were not statistically significant. 
 
 xiv 
Conclusion: This significant results of effectiveness of ginger as a preventive for post 
operative vomiting is a very promising finding in anaesthetic medical practices. We 
believe the positive result of ginger will be a catalyser for future study on the 
effectiveness of ginger in Malaysia. Ultimately, this will help in development of our 
holistic medicine in Malaysia.   
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CHAPTER ONE 
 
INTRODUCTION 
LITERATURE REVIEW 
 
 
 
1.1 Definition of post operative nausea and vomiting 
Nausea is an unpleasant sensation in the mouth and upper gastro intestinal tract 
(Dorland’s et al., 2001) that is associated with salivation and giddiness. It may lead to 
retching or contraction of upper gastro intestinal tract muscles in a reverse direction 
(John BW et al., 1990) that commonly ends up in throwing out content of stomach 
known as vomiting. The symptom of nausea and vomiting that happens during the 
period after reversal from anaesthesia following a surgery is post operative nausea 
and vomiting. Through literature reviews, the time period is generally taken up to 24 
hours post operatively. Post operative pain is undeniably the most worrying matter in 
any patient going for an operation. However, many adults find post operative nausea 
and vomiting more distressing than post operative pain itself. (Koivuranta M et al., 
1997) Since nausea is a subjective feeling, there is no objective 'standard' method for 
its measurement until today.  
 
1.2 Epidemiology of post operative nausea and vomiting  
The incidence of postoperative nausea and vomiting (ponv) in an untreated adult 
surgical population receiving general anaesthesia is around 20–30% as cited by 
Wengritzky et al. in 2010 but this increases up to 80% as elaborated by Myles et al in 
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2000 in patients with two or more risk factors for ponv. Overall, as discussed in 
related studies, the incidence of post operative nausea and vomiting in recovery room 
is 10% (Lerman J et al., 1992), but ranges from 20% to 30% during first 24 hours 
after surgery (Cohen MM et al., 1994, Quinn AC et al., 1994) 
Until late 1960’s, the period before introduction of modern anaesthetic agents, the 
incidence of ponv was significantly very high. It was the time when ether based 
anaesthetic agents was still commonly used. The incidence of post operative nausea 
and vomiting was as high as 80% in this ‘era of ether’. (Julien et al., 1992, Watcha 
MF et al., 1992)  
 
1.3 Risk factors for post operative nausea and vomiting 
A variety of risk factors have been observed and implicated in contributing post 
operative nausea and vomiting. (Ravikiran N et al., 2007) These factors are not 
necessarily treatable as it depends on the origin of the cause. The factors can be 
divided into patient-related, anaesthesia-related and surgery-related factors. In most 
of situation, the patient-related factors are non treatable. These patient-related factors 
are age, weight, gender, pre existing diseases, history of motion sickness or ponv, 
smoking habit, high level of anxiety and intercurrent illness. Anaesthesia-related 
factors are anxiolytics taken during pre medication, use of opioids for analgesia, other 
analgesics usage, reversal drugs usage, gastric distension, inadequate hydration and 
residual sympathectomy. The surgery-related factors are types of operative 
procedures, duration of surgeries, blood in gastro intestinal tract (GIT), forcing oral 
intake in post operative surgical wards, use of opioids, use of other analgesics, pre 
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mature ambulation (that cause postural hypotension) and pain. The surgical and 
anaesthetic origins are the possible avoidable and modifiable factors. (Islam S et al., 
2004, Haynes GR et al., 1996, Gan TJ et al., 2002, Korttila K et al., 1992, Apfel C et 
al., 2004 and Tramer MR et al., 2003) 
Types of the surgeries are an important predicament for post operative nausea and 
vomiting (ponv). Certain surgeries that involve abdominal and gynaecology are 
particularly emetogenic. The incidence of ponv following laparoscopic approach, 
such as laparoscopic cholecystectomy procedure is as high as 40%. (Nzoghe NP et 
al., 2001 and Hedayati B et al., 1999) Location of surgeries also plays an important 
role, typically surgeries in oral and throat, such as tonsillitis has shown to have higher 
incidences of ponv. The reason for high incidence of ponv in laparoscopic surgeries is 
due to significant increases in the intra abdominal pressure and diffusion of extra 
carbon dioxide gas during operation. Whereas, reason high incidence for surgeries in 
oral and throat are due to irritation in the upper airway and GIT, which leads to 
increase secretion and stimulation of gag reflex. Anaesthetic method, especially 
general anaesthesia causes higher incidence of nausea and vomiting in comparison to 
regional anaesthesia (Cohen et al., 1994) due to direct manipulation of upper airway 
and side effects of more than one anaesthetic drug. The inhalational agents are 
directly associated with nausea and vomiting. Inhalational agents, such as 
cyclopropane, are associated with high incidence, documented as high as 60% in the 
‘era of ether’ (Watcha MF et al., 1992) while isoflurane, enflurane and sevoflurane 
cause less nausea and vomiting. Intravenous anaesthetics are associated in influencing 
different degrees of emesis (Rabey PG et al., 1992) though the newer agent like 
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propofol is less emetogenic than the older anaesthetics. Opiods, such as morphine and 
pethidine, which are commonly used throughout surgery, are strong emetogens. 
(Kenny GN et al., 1994) It was noted that nausea and vomiting is three times more 
prevalent in adult female than in males (White PF et al., 1973 and Julien FB et al., 
1992). Previous history of motion sickness is a known risk factor. Smokers have 
decreased risk; however it would not be advised by any physician. Incidence is 
highest in paediatric age at pre adolescent of 11-14 years old (Rowley et al., 1982) 
and shows a trend of decreasing as age rises in adulthood. (Burthes P et al., 1957 and 
Julien FB et al., 1992) Explanation for aging process is the degenerative process that 
causes reduced reflexes in the physiological responses to vomiting stimuli. Obesity 
shows higher occurrence of nausea and vomiting because of inhalational agents are 
stored in adipose tissue and are slowly released into the bloodstream after operation 
(Palazzo MGA et al., 1984 and Julien FB et al., 1992).  
 
1.4 Physiology of post operative nausea and vomiting 
Vomiting is an important defence mechanism against ingestion of toxins. It also 
commonly happens as a non specific symptom during febrile illness and taking most 
of common medicines due to higher centre action (brain). In general, the act of emesis 
involves a sequence of events that are divided into three phases; pre ejection, ejection 
and post ejection phases. The pre ejection phase comprises of prodromal symptoms of 
nausea, along side with autonomic signs, such are salivation, swallowing, pallor and 
tachycardia. The ejection phase comprises of retching and vomiting. Retching is 
characterized by rhythmic, synchronous, inspiratory movements of the diaphragm, 
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involving all of the abdominal wall muscles together with external intercostal muscles 
of thorax. The mouth and glottis are kept closed with antral portion of the stomach 
contracts, the proximal portion relaxes and the gastric contents moves up and down 
between stomach and oesophagus. During retching, hiatal portion of the diaphragm 
does not relax; the increasing pressure of intra abdominal is associated with 
decreasing pressure in intra thoracic area. Vomiting, which is the expulsion of gastric 
contents, is the ultimate results of combination of contraction of the rectus abdominis 
and external oblique abdominis muscles, relaxation of the oesophageal sphincter, 
increase in intra thoracic and intra gastric pressure, reverse peristalsis motion of 
stomach and oesophagus with opened glottis and mouth. The post ejection phase 
consists of autonomic and visceral responses that return the body muscles to a relaxed 
phase, with or without residual nausea. The complex act of vomiting involves 
coordination of the respiratory, gastro intestinal and abdominal musculature. (Julien 
FB et al., 1992) This is controlled by an area in brain, called emetic centre. The 
evidence for such a centre is based on electrical stimulation on brain and brainstem 
lesion study. (Borison HL et al., 1989) Anatomic studies have shown that the 
parvicellular reticular formation has access to motor pathways that are responsible for 
the visceral and the somatic output involved in vomiting action. This area is situated 
in the lateral reticular formation close to tractus solitarius in brain stem and is 
believed to be the emetic centre. (Borison HL et al., 1989 and Andrews PLR et al., 
1990) Electrical stimulation of the emetic centre and tractus solitarius will cause 
immediate vomiting. Stimuli from several areas within the central nervous system can 
affect the emetic centre. These include afferents from the pharynx, gastro intestinal 
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tract and mediastinum, as well as afferents from the higher cortical centres (including 
visual centre and the vestibular portion of vestibulocochlear cranial nerve) and the 
chemoreceptor trigger zone (CTZ) in the postrema area. (Borison HL et al., 1989 and 
Andrews PLR et al., 1990) The postrema area is highly vascularized and the vessels 
terminate in fenestrated capillaries surrounded by large perivascular spaces. No 
effective blood brain barrier exists in this area and thus the CTZ can be activated by 
chemical stimuli received through the blood as well as the cerebrospinal fluid from 
sources like infection and its intermediates, medicines and injury or pressures in the 
brain. However, direct electrical stimulation of the CTZ does not result in emesis. 
(Borison HL et al., 1989) The area postrema of the brain stem is rich in dopamine, 
opioids and serotonin or 5-hydroxytryptamine type 3 (5HT3) receptors. The nucleus 
tractus solitarius is rich in histaminic and muscarinic cholinergic receptors. These 
receptors play an important role in the transmission of impulses to the emetic centre. 
 
      1.5 Measurement of nausea and vomiting 
Nausea is not an observable phenomenon. Thus, it is impossible for an observer to be 
aware that the patient is nauseated unless the patient tells the observer or doctor. 
Therefore, only patients can consent to allow nausea to be measured using a self 
report scale, or through an interview with the patient by a medical staff. 
Measurement of nausea and vomiting is important for the evaluation of efficiency of 
anti emetic treatment.  Frequency, duration and intensity of nausea will be assessed in 
all patients and clinical trial studies. Three different methods are commonly used 
which are: (i) Discrete Scale (DS), (ii) Visual Analogue Scale (VAS) and (iii) 
Continuous Chromatic Analogue Scale (ACCS) of measuring nausea and vomiting. 
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Four different dimensions are studied: (i) Maximal Intensity (MI), (ii) Entity (E), (iii) 
Duration (D) and (iv) Quantity (Q). (Faverol D et al., 1992) Many instruments are 
available and have been used to measure the quantitative and qualitative aspects of 
nausea but they have not been adequately validated and standardized. 
The measurement of frequency can be as simple as ‘yes or no’ answer to a specific 
question by the patient on the presence of nausea. It can also be measured based on a 
four to10 point scale. (Faverol D et al., 1992)  The duration of nausea has been 
reported as low in studies. This is because nausea is an intermittent phenomenon and 
it is difficult to measure. Thus, it requires frequent assessment. (Faverol D et al., 
1992) 
 
1.6 Effectiveness of metoclopramide used in post operative nausea and  
      vomiting  
Metoclopramide is an anti emetic and gastro prokinetic agent. It is primarily used to 
treat nausea and vomiting and to facilitate gastric emptying in patients with gastro 
paresis. The anti emetic action of metoclopramide is due to its antagonist activity at 
D2 (dopamine type 2 receptor) in the Chemo Triggering Zone (CTZ) in the central 
nervous system. This action prevents nausea and vomiting triggered by most stimuli. 
The prokinetic activity of metoclopramide is mediated by muscarinic activity; D2 
receptor antagonist and 5-hydroxytryptamine type 4 (5-HT4) receptor agonist 
activities. It increases peristalsis of the jejunum and duodenum, increases tone and 
amplitude of gastric contractions and relaxes the pyloric sphincter as well as duodenal 
bulb. Apart from preventing nausea and vomiting, metoclopramide is used to treat 
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heartburn caused by gastro oesophageal reflux in people who have used other 
medications without relief of symptoms. It is also used to treat slow gastric emptying 
in people with diabetes (also called diabetic gastro paresis), which can cause nausea, 
vomiting, heartburn, loss of appetite and a feeling of fullness after meals. However, 
metoclopramide should not be taken if patient has history of allergy to it, or if patients 
have bleeding or blockage in stomach or intestines, epilepsy or other seizures disorder 
of brain and adrenal tumour (phaechromocytoma). 
 
1.7 Effectiveness of ginger used in post operative nausea and vomiting 
Ginger is a plant that grows in warm climates countries like India, China and South 
Asia. The ginger plant belongs to Zingiberaceae family and is also known as Zingiber 
officinale Roscoe, and occasionally Z. capitatum or Z. zerumbet Smith
Ginger is a small plant, typically growing two to four feet in height. It has preferences 
in warm and humid climate. (Kathryn L et al., 2000) It has narrow, glossy, bright 
green leaves, and its summer flowers are yellowish green. The rhizome is the part 
used for culinary and medicinal purposes. In China and Japan, it is commonly been 
prescribed for headaches, nausea and other stomach problems and colds. 
. 
(DerMarderosian et al., 1990) The roots and rhizomes of ginger have played an 
important role in Indian, Chinese, Japanese, West Indies, South East Asia and African 
medicine. (DerMarderosian et al., 1990) Ginger has been promoted by people from 
these countries for various ailments, such as dyspepsia and loss of appetite, as well as 
an agent of carminative, antiemetic, gastrointestinal stimulant and antibacterial. (Liu 
WHD et al., 1990) 
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(Yoshikawan M et al., 1994) Ginger is famously, referred by these people as spicy 
and hot, that warms body and treat cold extremities, improves fatigability and 
strengthen body after blood loss. (Chang CP et al., 1995) In India, ginger is used in 
both fresh and dry powdered forms for cooking and Ayurvedic medical practice. 
(Sharma H et al., 1998) Ayurvedic practitioners describe ginger as pungent with a 
sweet aftertaste, ginger’s virya, or potency is hot. It is used to balance doshas (three 
organizing principles providing for homeostasis in Ayurvedic medicine), improves 
symptoms of colds and viral infections, enhances digestion, stimulate appetite and 
lessen arthritis. In some African countries like Nigeria, ginger has been used to treat 
malaria and yellow fever. Nevertheless, it has been used to treat urinary tract 
infections in West Indies. (Bone K et al., 1997) 
The rhizome contains different amounts of fatty oil, protein, carbohydrates, raw fiber 
and water, 2-4% volatile oil and 1% pungent substances. (DerMarderosian et al., 1999 
and Fleming T et al., 1998) The volatile oil contains various chemical components 
including zingiberene, zingiberol and camphorene, which gives ginger its 
characteristic aroma. (DerMarderosian et al., 1999, Liu WHD et al 1990 and Fleming 
T et al., 1998) The pharmacology activity of ginger is attributed to presence of the 
pungent substances of gingerols, shogaol, gingerdiones and zingerone. 
(DerMarderosian et al., 1999 and Fleming T et al., 1998) 
The mechanism of action of ginger in nausea and vomiting has not been fully 
explained. Nevertheless, studies suggest that its anti emetic action is likely based in 
the gastro intestinal tract as opposed to the central nervous system. (Lumb AB et al., 
1993 and Yamahara J et al., 1990) Holtmann et al. in 1989, studied response of 38 
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subjects to vestibular or ocular stimulation after premedication with placebo, ginger 
root and dimenhydrinate. They concluded that neither the vestibular nor the 
oculomotor system, both of which play a role in motion sickness, were influence by 
ginger. These observations and the lack of central nervous system side effects in the 
ginger group lead investigators to rule out central nervous system as site of 
mechanism of action for ginger in motion sickness. (Holtmann et al., 1989) In another 
specific study on mode of action of ginger using animal study, the conclusion has 
been that, the GIT, along the stomach and intestinal lumen is primary site for the 
action of ginger. The prokinetic action of ginger extract had shown presence of a 
unique combination of spasmonergic and spasmolytic activities mediated through 
cholinergic and calcium antagonist mechanism. (Muhammad NG et al., 1996)  
 
1.8 Justification of the Study 
Post operative nausea and vomiting is still one of the most common complaints in 
recovery rooms and post operative surgical wards. In spite of recent advances in 
modern medicine and anaesthetic practices, there has been no definitive gold standard 
anti emetic for prevention of post operative nausea and vomiting. (Tramer MR et al., 
2001 and 2003) Patients often rate ponv as worse than post operative pain. 
(Koivuntara M et al., 1997) It results in pain, haematoma, electrolytes imbalance with 
its complications and wound dehiscence, which causes delay in discharges and 
inevitably additional resources. (Nakata DA et al., 1999) Even though, multiple 
studies have been done in this field, the incidences of about 30% are still reported all 
over the world. This leaves a huge vacuum space for researches to do studies for 
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improvement in better management of post operative nausea and vomiting. There has 
not been a study done that looks specifically on the effectiveness of ginger for 
prevention of post operative nausea and vomiting in Malaysia. 
 
1.9 Objectives of Study 
General objective: 
The general objective of this study is to compare the effectiveness of tablet ginger 
against commonly used and established, tablet metoclopramide as an anti emetic 
agent to prevent post operative nausea, retching and vomiting in anaesthesia 
practices. 
Specific objective: 
1. To determine the association of tablet ginger and tablet metoclopramide in 
terms of clinical status of participants 
2. To compare tablet ginger and tablet metoclopramide in terms of  reducing 
incidence of  post operative nausea, retching and vomiting  
3. To determine the association of tablet ginger and tablet metoclopramide in 
terms of socio-demographic data 
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CHAPTER TWO 
 
MATERIALS AND METHODS 
 
 
2.1 Introduction 
This chapter describes the overall view of the designs used in the study. Details of the 
methodology are explained below. The study was conducted in Hospital Universiti 
Sains Malaysia (HUSM), Kota Bharu, in the state of Kelantan in Malaysia. 
 
2.2 Study design 
This is a double blinded randomized controlled trial study. The overall design is as 
depicted in Figure 2.0. 
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Flow Chart of Study Design and Research Methodology 
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Elective Surgical Patients in 
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Pre operative surgical patients in 
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      2.3 Study population and sample  
The source population are patients who were scheduled for elective surgeries in 
Hospital Universiti Sains Malaysia (HUSM) with mild to moderate risk to general 
anaesthesia. The patients were categorised using American Society of 
Anaesthesiologists (ASA) physical health status grading system with grade 1, which 
refer to patients who had no underlying medical illness and was in good health for 
operation. Grade 2 ASA was used to refer to patients who had good control of 
underlying medical conditions or disease with or without medications. Patients were 
categorised into four main disciplines of surgeries which were; (i) General Surgery, 
(ii) Orthopaedic, (iii) Otorhinolarhingology and (iv) Gynaecology. Selection of 
patients was done by screening patients using inclusion and exclusion criteria. These 
criteria are as shown in Table 1. The demographic characteristic information recorded 
from the sample population were (i) Age, (ii) Gender, (iii) Race, (iv) Height and 
weight with body mass index, (v) Clinical status in ASA grading, (vi) Relevant 
investigations and (vii) Type of operations. These data is shown in Appendix 2, the 
Data Collection Observational Indicator form. 
 
2.4 Study Setting and Period of Study 
The study was conducted in Hospital Universiti Sains Malaysia (HUSM) within a 
period of fifteen (15) months from July 2009 till October 2010. Patients were 
included in the study, 1 day prior to their operation. They were given explanation and 
recruited after they agreed to give a written consent in ward. They would be followed 
up from the time of post operative period in recovery, right up to 24 hours after the 
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time they were reversed from anaesthesia for their operation. Some of these patients 
were contacted through phone at home, as they were discharged within that 24 hours 
period in view of their good clinical recovery by their managing doctor in ward. 
 
This inclusion and exclusion criteria are as shown in the table below. 
 
      Table 2.1 Inclusion and Exclusion Criteria 
INCLUSION CRITERIA EXCLUSION CRITERIA 
ASA Physical Health Status 
Grade 1 
Emergency surgery  
 
ASA Physical Health Status 
Grade 2 
 
Patients who had vomited or had 
received any antiemetic within 24 hours 
prior to surgery 
 
Age between 18-70 ASA Physical Health Status Grade 3 to 5 
Scheduled for elective surgery Patients with psychiatric illnesses 
 
History of drug dependence or 
alcoholism 
 
 Pregnant Ladies 
 Patient who has recent history of taking 
ginger in any form or taken any anti 
emetic (within 24 hours) 
 
Key: ASA = American Society of Anaesthesiologists 
(Grading system of  physical status of patients going for operation) 
 
 
Patients were screened and recruited using inclusion and exclusion criteria. The 
inclusion criteria are: (i) Elective surgical patients, (ii) Aged between 18 till 70 years 
old and (iii) Pre-operative ASA physical health status grading system category one 
and two. Patients were excluded from the study if, they had: (i) Emergency surgeries, 
Formatted: Indent: Left:  0.63 cm,
Line spacing:  single
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Line spacing:  single
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(ii) ASA physical health status of grading system category three onwards, (iii) 
Psychiatric disturbance that precluded complete cooperation, (iv) History of alcohol 
or drug dependence, (v) Distress or any severe pre-existing medical conditions that 
limited objective assessment after operation, (vi) Patients, who had taken ginger in 
form of supplement or in their food or taken any type of anti emetic within 24 hours 
prior to operation, (vii) Pregnant ladies and (viii) Presence of any life-threatening 
postoperative complications. This criterion was modified from Wengritzky et al. 
published in 2009. Based on the inclusion and exclusion criteria, 70 patients were 
recruited into this study. 
 
2.5 Sampling method and sample size determination 
The sample size was calculated using the formula below using 80% power, alpha 0.05 
and drop out rate of 20%. 
 
 
 
Where; n= is sample size; α=alpha; β=beta; P1 is the metoclopramide group 
(control group); P2 is the ginger group (experimental group) 
 
Based on this formula, the required sample was 330 patients. However, after multiple 
discussion sessions with supervisors and anaesthetists in Department of 
Anaesthesiology, HUSM, we have made a decision to include only 70 patients in this 
 
n = P1(1-P1)+P2(1-P2) 
           (P1 - P2)² 
∫αβ 
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study. The reasons were: (i) Due to short period of time, (ii) Resources factors that 
were limited and (iii) This will become a ‘Pilot Study’ in the university (USM). 
Recalculation for sampling was 35 in each group after considering 20% drop out. The 
final calculation after drop out was 36 in group A and 34 in group B. 
 
2.2.3      2.5.1 Expected limitation (expected drop-out) 
The potential expected limitations of study were (i) patient’s refusal in any stage of 
study period, (ii) cancellation of operation, (iii) incomplete data form (DCOI) entries, 
(iv) complicated cases that required long duration operation time. 
 
      2.6 Description of the data collection instrument  
Literature search was done and the data collection observation form was developed 
based on literature search and review.  The demographic data of observation form 
was taken from Muhammad Jamil’s creation in 2005 at Ayub Medical College, 
Abbottabad. Demographic variables included were age, sex, race, height, weight, 
body mass index, education level and status of employment. 
The section on clinical status included were diagnosis, type of surgery, duration of 
surgery, underlying illness, vital signs, height, weight, body mass index (BMI), 
laboratory results and pre operative physical health status.  
In addition, the measurement for nausea, retching and vomiting was modified and 
incorporated from the ‘Index of Nausea and Vomiting’ that was developed by Rhodes 
et al. in 1984, who measured 3 dimensions, nausea, retching and vomiting. This ‘Data 
Collection Observation Instrument’ (DCOI) also included operative procedures and 
Formatted: Bullets and Numbering
 18 
pre operative drug treatment for nausea and vomiting, types and dosage of analgesia 
agents administered (total amount of fentanyl and parecoxib given). The BMI was 
calculated from weight and height of the patient. The calculation of BMI is weight (in 
kilograms) divided by height (in metres) multiplied by height (in metres). In view of 
majority of patients were Malay (94%), the race was recategorized to Malay and non-
Malay.  
Scoring system was divided into 3 tables, which requires observation of the three 
symptoms of nausea, retching and vomiting. An important matter to know here is that 
all these 3 symptoms are related to each other especially when vomiting is produced. 
This physiological relation was explained in chapter one. The severe the symptom, 
the higher class it will be scored in this data collection observational instrument 
(DCOI). Each table, also scores the time, at when this symptom occurs. Time is 
referred to as the time, a studied symptom occurs from the time of post operative 
period (reversal from anaesthesia). Patient’s response to either study drugs were 
scored in periodic tables that also look into degree of severity of these symptoms. 
 
2.7 The Procedure 
A preliminary survey was done to find out the number of operations performed in 
operation theatres in HUSM from the medical records and surgical admission books. 
This survey was done to ensure the possibility of achieving an adequate sample size 
using inclusion and exclusion criteria. The DCOI was evaluated. The finding of the 
survey was discussed and adjustments were made until it was feasible to do the study. 
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Content and face validity was done among the specialists in the Anaesthesiology 
Department of HUSM. 
A written consent was given to patient to be kept for their reference. Patients were 
informed about the study flows, their rights as a study participant with necessary 
contact numbers and addresses of the research faculty and researchers. They received 
explanations about the procedures of the study and possible risks involves by an 
anaesthetic medical officer on duty. Patients would sign if they agreed. They were 
given the option to withdraw at any time during the study. 
Patients, who fulfilled the criteria at the admission day, which was 1 day prior to 
operation, will be included in the study. Selected patients were grouped into Group A 
and Group B in a double blinded method. Group A was given tablet metoclopramide 
while group B was given tablet ginger at approximately 30 minutes prior to 
anaesthesia. Study drug A is metoclopramide; it is in tablet form, round shaped, white 
coloured, with dosage of 10 mg. It is readily available and prescribed in Malaysian 
Ministry of Health (KKM) hospitals in Malaysia. Its chemical or systemic name is 4-
amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide. Whereas, the 
experimental drug B; tablet ginger was almost identical. The ginger tablet was round 
shaped, white coloured with dosage of 400 mg of Zingiber officinale root powder. 
Two tablets of ginger drug will be used to get a dose of 800 mg. Its size is slightly 
bigger than metoclopramide at about 2.5 mm differences in diameter. The ginger 
tablet was manufactured by Blackmores LTD, Australia with a Malaysian Ministry of 
Health approval. Number of approval is MAL 06051553TCR. Many efforts were 
made to make the study tablets double blinded among the medical staffs and patients 
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involved in the study. These efforts were: (i) both metoclopramide and ginger tablets 
were sealed in exactly same type of white mini medication pack, measuring about 3 
cm by 6 cm and labelled respectively with capital A and B, where A was blinded 
metoclopramide tablet and B was blinded ginger tablets, (ii) all the sealed tablets 
were mixed in a random manner and kept together in a wrapped square shaped box, 
measuring about 35 cm by 13 cm by 10 cm in dimension with a small oval shaped 
opening on top and (iii) the preparation and allocation of the drugs were done by a 
person who is not involved in administrating the drug or documenting observation of 
patient’s conditions intra operatively as well as post operatively. 
A standard anaesthesia technique was used for all the patients. Induction of 
anaesthesia was performed with intravenous (IV) fentanyl 1.0 mcg/kg, followed by 
IV 1 % propofol 1.5 mg/kg. If ventilation was good and adequate through manual 
bagging, then IV rocuronium 0.6mg/kg used to paralyze and facilitate intubation. 
Ventilation of paralyzed patient was controlled mechanically to achieve tidal 
volume of 8-10 ml/kg and respiratory rate maintained based on end tidal carbon 
dioxide (ETCO2) guidance to achieve value of 35 to 45 mmHg. 
Intra operatively, patient’s anaesthesia was maintained with IV rocuronium 0.2 
mg/kg at interval of 30 to 40 minutes as required and IV fentanyl 0.5 mcg/kg as 
required, (the total amount of fentanyl required will be evaluated). No morphine 
was used in the study. Oxygen and air at 50% ratio and sevoflurane were 
maintained at 2%. Nitrous oxide was also not used in this study. Data collections 
intra operatively were heart rate, systolic and diastolic blood pressure were 
obtained via non-invasive monitoring at regular intervals of 10 minutes during 
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operation. At the completion of the surgical procedures, both study groups of 
patients were reversed with IV neostigmine 0.05 mg/kg and IV atropine 0.02 
mg/kg.  Once stable, the patients were monitored closely in the recovery bay. 
Rescue antiemetic, IV ondansetron 150 mcg/kg was kept in emergency trolley 
throughout the period of the study. 
Post operatively, all patients were observed and recorded for clinical 
manifestations for 24 hours. The times of onset of the manifestations were grouped 
into three periods of time which are: (i) zero   to six hours (immediate), (ii) more 
than six hours to twelve hours (intermediate) and (iii) more than twelve hours to 24 
hours (delayed). The onset and manifestation of nausea, retching and vomiting 
were recorded with a standard scaling system for all study subjects as shown 
below.  
The scaling for nausea is as follows:  
0 –No discomfort in mouth and throat 
1 –Feeling of discomfort in mouth or throat, with or without giddiness (mild) 
2 –No 1 associated with giddiness with or without increase salivation (moderate) 
3 –No 2 associated with increase salivation and pre vomiting pressure (severe) 
 
The scaling for retching is as follows: 
0 –No pressured feeling in mouth or throat 
1 –Feeling of increase pressure without vomiting (mild) 
2 –No 1 with gag reflex (moderate) 
3 –No 2 with vomitus taste without vomiting (severe) 
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The scaling for vomiting is as follows: 
0 –No vomiting 
1 –Minimal vomitus and stops immediately (mild) 
2 –Large amount of vomitus and stops after one projectile action (moderate) 
3 –Large amount of vomitus with more than one episode (severe) 
(Please refer to Appendix 2, the DCOI form) 
 
2.8 Ethical Issues 
The study was presented to Research Ethics Committee (Human) of Universiti Sains 
Malaysia (USM) on 28th September 2009. Issues discussed were introduction of a 
new drug, ginger tablet for patients in the study, patient’s flexibility in accepting as a 
participant and their confidentiality. 
Ethical committee were pleased to approve as the ginger tablet is from an approved 
source (by Malaysian Ministry of Health) and generally ginger is widely taken by 
local community in their daily food. Date of approval is 8th October 2009 (Ref. No. 
USMKK/PPP/JEPeM [217.3.(02). (Please refer to Appendix 1) 
 
2.9 Statistical Analysis 
Descriptive and inferential statistics were used to analyze the data. Data was checked, 
explored and cleaned using PASW version 18.0. Descriptive statistics were used for 
demographic data. Means, standard deviations, medians and inter-quartile ranges 
were calculated for numerical variables. Frequency and percentages were calculated 
for categorical variables.  
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Simple logistic regression was done to test at univariate level the associated study 
factors with post operative nausea, retching and vomiting (PONRV) as dependent 
variable. The results of simple logistic regression values, the crude odds ratio (OR), p 
value and 95% confidence interval (CI) were recorded for each variable. In all 
statistical analyses, P < 0.05, was taken as statistical significant. The data was 
presented with p values as well as 95% confidence intervals whenever appropriate. 
To compare the socio-demographic characteristics and clinical variables, chi-square 
(χ²) test was used for categorical values. Multiple logistic regression was performed 
to the model for the associated factors of post operative nausea, retching and 
vomiting. This, multiple logistic regression analysis was used to control the 
confounders, at the same time, to detect the association of each factor to post 
operative nausea, retching and vomiting independently. Interaction term between 
independent variables, multicollinearity problem and model assumptions were 
checked for each model.  Steps in modelling multiple logistic regression were; (i) 
Univariable analysis, (ii) Variable selection, (iii) Check multicollinearity, (iv) Check 
2-way interaction term, (v) Assess the goodness-of-fit of the model and (vi) Establish 
final model. 
Inferential statistics were used to compare differences of effectiveness of Drug A 
versus Drug B between the two groups.  Independent t-test was used to study the 
effectiveness of the two study drugs against relation with BMI and duration of 
operation. Chi-square test was used to look for effectiveness of the two study drugs 
against gender and occupation. Whereas, Fisher’ exact test was used to look for 
effectiveness of the two study drugs against ASA grading and races. The presence of 
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nausea, retching and vomiting in both study drugs were analysed with Fisher’s exact 
test for duration of 0 to 6 hours and more than 6 hours to 12 hours, except for nausea 
within 6 hours period, which was analysed with Chi-square test.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
